 오퍼게시판 |
|
|
 |
|
|
 |
제 목:
|
Yinherb Supply Nootropics Nsi-189 Freebase Nsi-189 Phosphate Raw Powder |
|
등록분류: |
Offer to Sell |
|
내용: |
CAS NO: 1270138-41-4
Quantity: 500Kilograms
Price: 500USDKilograms
Payment: T/T, Western Union, Money Gram, Bitcoin
Additional_detail: Yinherb Lab NSI-189 Phosphate Bulk Raw Powder 99% Purity
Product Name: NSI-189 Phosphate
CAS:1270138-40-3
MF:C22H30N4O
Synonyms:NSI-189;[2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone;[2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone
Appearance: White Fine??Powder?
Capacity: 1000kgs per month
Source: synthetic
Purity (HPLC) >99.0%
Place of Origin: China Yinherb-Lab
Packing: As per client's requirements
Minimum Order Quantity: 1kg
Storage: Store in cool &?dry place, Keep away from strong light and heat for 2?years
What is NSI-189 Phosphate?
NSI-189 is neurogenic and nootropic research agent that was developed from nicotinamide and pyrazine. Randomized controlled trials have shown that it stimulates neurogenesis or neuronal cell production in the brain. In animal studies, it has also been shown to increase the volume of hippocampus by 20% thereby reversing behavioral symptoms of depression. Such studies have shown that it may be an effective treatment for depression. It is also thought to be a?promising treatment for other condition including post-traumatic stress disorder (PTSD), Alzheimer's disease and age-related cognitive problems.
NSI-189 Phosphate?Benefits
1.Nsi-189 can Enhance cognition and memory formation.
2.Nsi-189 can Anxiolytic properties.
3.Nsi-189 can Anti-depressive effect .
4.Nsi-189 can Treatment of Alzheimer's and Parkinson's disease.
5.Nsi-189 can Increase coordination.
6.Nsi-189 can Improves mood.
7.Nsi-189 can Help fight fatigue.
8.Nsi-189 can Prevent oxidation within the brain.
9.Nsi-189 can Treat alcohol related brain damage.
10.Nsi-189 can Prevent caffeine withdrawal symptoms.
NSI-189 Phosphate Mode of Action
NSI-189 Phosphate is a?proprietary new chemical entity that stimulates new neuron growth in the hippocampus, an area of the brain believed to be contributory in MDD and other conditions, such as Alzheimer's disease and Post-traumatic stress disorder (PTSD). Phase 1b of the clinical trial is to test the safety and tolerability of the drug in depressed patients.
|
연락처 |
|
현재위치
: Home > Trade 
